Psoriasis: A Th17 autoimmune disease on the rise
Plaque psoriasis affects 2–3% of the Belgian population (200,000–300,000 patients). Central mechanism: Th17 immune dysregulation → overproduction of IL-17A, IL-17F, IL-22, and IL-23 → keratinocyte activation → epidermal hyperproliferation (3–4 day cycle instead of 28 days) → thick, scaly, itchy plaques. Preferential locations: elbows, knees, scalp, lumbosacral area.
Psoriasis is also a systemic disease: cardiovascular comorbidities, psoriatic arthritis (20% of patients), metabolic syndrome, depression. Systemic inflammation is the common denominator.
Mechanisms of ginger on psoriasis
1. Inhibition of the Th17/IL-17/IL-23 axis
The most effective biologics against psoriasis specifically target IL-17 (secukinumab, ixekizumab) or IL-23/p19 (guselkumab, risankizumab). These drugs cost €10,000–€20,000/year. Ginger acts upstream: 6-gingerol inhibits the differentiation of Th0→Th17 lymphocytes by reducing IL-6 and TGF-β (cytokines necessary for this differentiation). Result: less Th17 → less IL-17 → less keratinocyte activation.
2. Inhibition of NF-κB in keratinocytes
Psoriatic keratinocytes have constitutionally activated NF-κB → production of IL-8 (neutrophil attraction), IL-6, CXCL1 → maintenance of the inflammatory loop. Ginger inhibits NF-κB in keratinocytes → reduction in the production of these chemokines → less influx of immune cells into the plaque → regression of lesions.
3. Reduction of keratinocyte proliferation (Nrf2)
Abnormal keratinocyte proliferation is mediated by EGF-R (epidermal growth factor receptor) and JAK-STAT. Nrf2, activated by ginger, modifies the expression of cell cycle regulators → slows down epidermal proliferation. In parallel, oxidative stress is reduced → less activation of keratinocytes by ROS.
4. Psoriatic arthritis: joint protection
Psoriatic arthritis combines skin inflammation with joint inflammation (synovial, entheses). Ginger → inhibition of MMP-3 and COX-2 in the joints → less bone erosion and joint pain → dual benefit for skin and joints.
Topical vs. systemic use
- Oral (shots): systemic action on the Th17 axis, NF-κB, reduction of systemic inflammation and cardiovascular comorbidities
- Topical (diluted ginger oil): local anti-proliferative and anti-itch action. Dilute 2–3% in a carrier oil (jojoba, argan). DO NOT apply pure — risk of irritation on damaged skin.
Psoriasis protocol
| Phase | Oral Dose | Topical |
|---|---|---|
| Months 1–2 (loading) | 3× 60ml/day | 2×/day on plaques (diluted) |
| Months 3–6 (maintenance) | 2× 60ml/day | 1×/day as prevention |
| Severe flare-up | 3× 60ml + dermatologist | Alternate with topical corticosteroid |
FAQ — Ginger and psoriasis
Does ginger interact with biologics (Stelara, Cosentyx, Skyrizi)?
No known pharmacokinetic interactions. Complementary mechanisms: biologics block specific cytokines downstream, ginger acts upstream on Th17 differentiation. Inform your dermatologist.
Is it effective for scalp psoriasis?
Yes — the systemic action (oral) benefits all locations. For the scalp, a rinse with lemon water + a few drops of ginger extract can complement the action.
Can psoriasis be completely cured with ginger?
Psoriasis is a chronic genetic disease — no treatment cures it. Ginger can induce prolonged remission in patients with mild to moderate psoriasis, and significantly improve more severe psoriasis in combination with dermatological treatment.
IL-17, IL-23, Th17 — the same targets as biologics, naturally.
→ Order on inti-drink.com
Related articles
To learn more, also read:
- Ginger and autoimmune skin diseases: advanced psoriasis, vitiligo and lichen planus — IL-17, Nrf2 and melanocytes
- Ginger & Psoriasis / Eczema: anti-inflammatory-science-utilisation">natural anti-inflammatory Cutaneous, Pruritus and Skin Healing
- Ginger and Psoriasis: Cutaneous Inflammation, IL-17 & Plaques
- Ginger and eczema: anti-inflammatory effects on atopic dermatitis
- Ginger and psoriasis: anti-inflammatory effects on the skin
- Ginger and Acne: Sebum, Follicular Inflammation & Propionibacterium
- Ginger and Psoriasis: Cutaneous Inflammation, TNF-α & Keratinocytes
- Ginger and Eczema (Atopic Dermatitis): Pruritus, Skin Barrier & IL-4